Gardasil may not be cost-effective for boys

October 9, 2009 The Food and Drug Administration is weighing whether to approve Gardasil for use in males ages 9 to 26 to protect them from genital warts.

The Centers for Disease Control and Prevention recommends the shot for females ages 11 to 26.

Merck, the company which makes Gardasil, is now seeking approval for use in boys and men.

Government researchers say clinical trials show that the vaccine offers a high degree of protection, but might not be worth the cost of routine vaccinations for males.

Copyright © 2023 WLS-TV. All Rights Reserved.